Common Contracts
2 similar Non-Disclosure Agreement contracts by Omrix Biopharmaceuticals, Inc.
ContractNon-Disclosure Agreement • May 5th, 2020
EX-99.E.3 3 y72866d9exv99wew3.htm EX-99.E.3: NONDISCLOSURE AGREEMENT Execution Copy Exhibit (e)(3) NONDISCLOSURE AGREEMENT Disclosing Party: Omrix Biopharmaceuticals, Inc. Recipient: Ethicon, Inc. This NONDISCLOSURE AGREEMENT (this “Agreement”) is made effective as of the 1st day of August, 2008, by and between Omrix Biopharmaceuticals, Inc. (the “Company”) and Ethicon, Inc. (the “Recipient”) to assure the protection and preservation of the confidential and/or proprietary nature of information to be disclosed to the Recipient by the Company. WHEREAS, in order to pursue negotiations or discussions in contemplation or furtherance of a business relationship between the parties or strategic transaction involving the parties, the Company has agreed to disclose and the Recipient has agreed to receive certain data and other information which are of a proprietary and confidential nature (as defined in Paragraph 1 below and referred to herein as “Confidential Information”). The Confidential Inf
NONDISCLOSURE AGREEMENT Disclosing Party: Omrix Biopharmaceuticals, Inc. Recipient: Ethicon, Inc.Non-Disclosure Agreement • November 26th, 2008 • Omrix Biopharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This NONDISCLOSURE AGREEMENT (this “Agreement”) is made effective as of the 1st day of August, 2008, by and between Omrix Biopharmaceuticals, Inc. (the “Company”) and Ethicon, Inc. (the “Recipient”) to assure the protection and preservation of the confidential and/or proprietary nature of information to be disclosed to the Recipient by the Company.
